Dr. Federman on Ongoing Research in Rare Bone and Soft Tissue Sarcoma

Partner | Cancer Centers | <b>UCLA Health Jonsson Comprehensive Cancer Center</b>

Noah Federman, MD, director, Pediatric Bone and Soft Tissue Sarcoma Program, University of California, Los Angeles (UCLA), discusses ongoing research in rare bone and soft tissue sarcoma.

Noah Federman, MD, director, Pediatric Bone and Soft Tissue Sarcoma Program, University of California, Los Angeles (UCLA), discusses ongoing research in rare bone and soft tissue sarcoma.

Current research at UCLA’s Jonnson Comprehensive Cancer Center is focused on patients with rare bone and soft tissue sarcoma, which generally occur in children, adolescents, and young adults, Federman says. One ongoing clinical trial is looking at imaging with PET/CT scans to more accurately diagnose and stage these diseases, as well as observe responses to therapies.

A second trial is examining the efficacy of novel targeted chemotherapy agents toward ewing sarcoma and rhabdomyosarcoma. It is hopeful that these agents will improve patient outcomes, Federman says.